These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34794852)

  • 21. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
    González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
    Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. QT Interval Monitoring and Drugs Management During COVID-19 Pandemic.
    Gasperetti A; Schiavone M; Tondo C; Mitacchione G; Viecca M; Galli M; Sarzi-Puttini P; Forleo GB
    Curr Rev Clin Exp Pharmacol; 2021; 16(4):306-317. PubMed ID: 33357185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.
    Uzunova K; Filipova E; Pavlova V; Vekov T
    Biomed Pharmacother; 2020 Nov; 131():110668. PubMed ID: 32861965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergency Regulatory Procedures, Pharmaceutical Regulatory Politics, and the Political Economy of Vaccine Regulation in the COVID-19 Pandemic.
    Nachlis H; Thomson K
    J Health Polit Policy Law; 2024 Feb; 49(1):73-98. PubMed ID: 37522337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial.
    Akram J; Azhar S; Shahzad M; Latif W; Khan KS
    Trials; 2020 Aug; 21(1):702. PubMed ID: 32771032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals.
    Mallhi TH; Ahmad A; Butt MH; Misbah S; Khan YH; Alotaibi NH
    J Coll Physicians Surg Pak; 2020 Oct; 30(10):124-128. PubMed ID: 33115586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic.
    Tripathy S; Dassarma B; Roy S; Chabalala H; Matsabisa MG
    Int J Antimicrob Agents; 2020 Aug; 56(2):106028. PubMed ID: 32450198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repurposed drug studies on the primary prevention of SARS-CoV-2 infection during the pandemic: systematic review and meta-analysis.
    Zhou G; Verweij S; Bijlsma MJ; de Vos S; Oude Rengerink K; Pasmooij AMG; van Baarle D; Niesters HGM; Mol P; Vonk JM; Hak E
    BMJ Open Respir Res; 2023 Aug; 10(1):. PubMed ID: 37640510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial.
    Vallejos J; Zoni R; Bangher M; Villamandos S; Bobadilla A; Plano F; Campias C; Chaparro Campias E; Achinelli F; Guglielmone HA; Ojeda J; Medina F; Farizano Salazar D; Andino G; Ruiz Diaz NE; Kawerin P; Meza E; Dellamea S; Aquino A; Flores V; Martemucci CN; Vernengo MM; Martinez SM; Segovia JE; Aguirre MG
    Trials; 2020 Nov; 21(1):965. PubMed ID: 33234158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening of Chloroquine, Hydroxychloroquine and its derivatives for their binding affinity to multiple SARS-CoV-2 protein drug targets.
    Nimgampalle M; Devanathan V; Saxena A
    J Biomol Struct Dyn; 2021 Sep; 39(14):4949-4961. PubMed ID: 32579059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial.
    Denholm JT; Davis J; Paterson D; Roberts J; Morpeth S; Snelling T; Zentner D; Rees M; O'Sullivan M; Price D; Bowen A; Tong SYC;
    Trials; 2020 Jul; 21(1):646. PubMed ID: 32665040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydroxychloroquine Pre-Exposure Prophylaxis for COVID-19 in Healthcare Workers from India: A Meta-Analysis.
    Stricker RB; Fesler MC
    J Infect Public Health; 2021 Sep; 14(9):1161-1163. PubMed ID: 34391171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Science-related populism declining during the COVID-19 pandemic: A panel survey of the Swiss population before and after the Coronavirus outbreak.
    Mede NG; Schäfer MS
    Public Underst Sci; 2022 Feb; 31(2):211-222. PubMed ID: 34758659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Health professionals facing the coronavirus disease 2019 (COVID-19) pandemic: What are the mental health risks?].
    El-Hage W; Hingray C; Lemogne C; Yrondi A; Brunault P; Bienvenu T; Etain B; Paquet C; Gohier B; Bennabi D; Birmes P; Sauvaget A; Fakra E; Prieto N; Bulteau S; Vidailhet P; Camus V; Leboyer M; Krebs MO; Aouizerate B
    Encephale; 2020 Jun; 46(3S):S73-S80. PubMed ID: 32370984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
    Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
    Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medication of Hydroxychloroquine, Remdesivir and Convalescent Plasma during the COVID-19 Pandemic in Germany-An Ethical Analysis.
    Voit K; Timmermann C; Steger F
    Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34073254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 'I hope you die': how the COVID pandemic unleashed attacks on scientists.
    Nogrady B
    Nature; 2021 Oct; 598(7880):250-253. PubMed ID: 34645996
    [No Abstract]   [Full Text] [Related]  

  • 39. Test and treat COVID 65 plus - Hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of older patients with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Göpel S; Bethge W; Martus P; Kreth F; Iftner T; Joos S; Döbele S; Mordmüller B; Kremsner P; Ettrich T; Seufferlein T; Bitzer M; Malek N
    Trials; 2020 Jul; 21(1):635. PubMed ID: 32650818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.
    Bosaeed M; Mahmoud E; Hussein M; Alharbi A; Alsaedy A; Alothman A; Aljeraisy M; Alqahtani H; Nashabat M; Almutairi B; Almaghaslah M; Aldibasi O; AlJohani S; Bouchama A; Arabi Y; Alaskar A
    Trials; 2020 Oct; 21(1):904. PubMed ID: 33129363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.